Skip to content
Open access

Integrated gut microbiota and metabolome analyses link anger to metabolic dysregulation in patients with type 2 diabetes mellitus

Jul 2026 · Frontiers in Microbiology · Vol 17 · 0 citations · 60 references
Medicine

TL;DR

VAS-defined irritability symptoms were associated with specific gut microbial and metabolomic alterations in T2DM, providing exploratory evidence for future studies on emotion-related metabolic dysregulation.

Abstract

Objective This exploratory pilot study aimed to investigate the associations of anger-related irritability symptoms with gut microbiota and circulating metabolites in patients with type 2 diabetes mellitus (T2DM) using multi-omics analysis. Methods We conducted a cross-sectional study, in which T2DM patients were categorized into a self-reported irritable T2DM group (IDM, n = 29) and a self-reported non-irritable DM group (NIDM, n = 28) based on Visual Analog Scale (VAS) scores, with a healthy control group (HC, n = 30) also established. Fecal 16S rRNA gene sequencing and UPLC-MS/MS-based untargeted metabolomic profiling of blood samples were performed. Differences in microbial community structure between groups were analyzed using alpha and beta diversity metrics and linear discriminant analysis effect size (LEfSe) analysis. Differentially abundant genera were identified by MaAsLin2 with adjustment for confounders. Exploratory metabolite markers were screened based on thresholds for p < 0.05, variable importance in projection (VIP) > 1, |log2 fold change (FC)| > 1. Associations between differentially abundant genera and exploratory metabolite markers were explored using Spearman correlation analysis. Functional prediction was conducted based on differentially represented KEGG orthology (KO) and clusters of orthologous groups (COG) entries to identify altered metabolic pathways. Results Both beta diversity and LEfSe analyses revealed differences in gut microbial community structure and potential discriminatory taxa among the three groups. Five differentially abundant genera and twelve exploratory metabolite markers were identified between IDM and NIDM. A combined model incorporating microbial and metabolomic markers demonstrated superior diagnostic performance (AUC = 0.872) compared with models using either type of marker alone. Twelve statistically significant microbiota–metabolite associations were found in Spearman analysis. Functional prediction analysis indicated enrichment of bile acid and tryptophan metabolism pathways. Conclusion VAS-defined irritability symptoms were associated with specific gut microbial and metabolomic alterations in T2DM, providing exploratory evidence for future studies on emotion-related metabolic dysregulation.

Read PDF

Similar papers

Open access Oct 2026

An exploratory study of gut microbiota and serum metabolite profiles in type 2 diabetes patients with sleep disorders

To characterize gut microbiota composition and serum metabolites in T2DM patients with and without sleep disorders. This single center cross sectional study enrolled 40 T2DM patients with sleep disorders (Group I), 40 T2DM patients without sleep disorders (Group N) and 30 age and sex matched healthy controls...

Jin-Kun Ma, Xin-Bin Zhang, Yi-Rao Pan et al. · 0 citations
Sep 2026

Integrated metabolomic and genetic profiling implicate loss of docosahexaenoic acid in the link between ultra-processed foods and Crohn's disease.

Lower circulating DHA may represent one metabolic pathway linking UPF intake to increased CD risk, apart from additive harm to metabolic depletion, which highlights potential targets for precision nutrition in CD prevention in future trials.

Si-Dan Wang, Lin-Tao Dan, Xi-Xian Ruan et al. · 0 citations
Open access Sep 2026

Integrated metagenomic and metabolomic analysis identifies severity-specific inflammatory and metabolic signatures in post-stroke depression

Multi-omics clues suggesting associations between different PSD severity levels and features such as increased Alistipes abundance, reduced antioxidant capacity, and altered tryptophan metabolism are provided, but still require validation in larger samples, longitudinal cohorts, and mechanistic studies.

Wen-Yi Chen, Ya-Wen Pan, Meng-Yuan Chen et al. · 0 citations
Open access Sep 2026

Dietary index for gut microbiota (DIGM) and cardiometabolic, inflammatory, and gut–brain-related biomarkers in adults with obesity: a cross-sectional study

Background The gut microbiota plays an important role in metabolic homeostasis and systemic inflammation, and dietary habits are major determinants of its composition and function. This study investigated the association between adherence to the Dietary Index for Gut Microbiota (DIGM) and cardiometabolic, inflammatory,...

Amr A. El-Sehrawy, Ismail Kandil, Safa Labib et al. · 0 citations
Open access Oct 2026

Altered gut microbiota and untargeted metabolomic features in patients with schizophrenia: a case–control study

Mental disorders are among the leading causes of global disease burden, and their etiology spans genetic, environmental, and physiological factors. Emerging evidence suggests that the gut microbiota may contribute to the development of neuropsychiatric disorders through the microbiota–gut–brain axis. This study aim...

Yun-Qiang Mi, Peng Sun, Qing-Rui Hao et al. · 0 citations
Open access Oct 2026

Identification of Genes Associated with Gut Microbiota Metabolites in Type 2 Diabetes Mellitus Complicated by Acute Cerebral Infarction Based on Bioinformatics and Mendelian Randomization

Background: Type 2 diabetes mellitus (T2DM) and acute cerebral infarction (ACI) are globally prevalent diseases that impose substantial public health burdens. While gut microbiota (GM) is increasingly recognized to regulate metabolic and immune homeostasis linked to both diseases, its shared genetically predicted micro...

Gui-Mei Zhang, Jia-Sheng Ju, Run Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.